Key Facts

Founded May 10, 1876

Headquarters located in Indianapolis, Indiana, U.S.A and operates in 120 countries

Lilly introduced the world's first commercial insulin in 1923.

Approximately 33,000 employees worldwide.

More than 7,700 employees engaged in research and development.

Products marketed in 120 countries.

R&D expenses (2019) $21.5 million  

R&D as a percentage of sales: 25.1% 

Percentage of total workforce engaged in R&D: 23% 

Research and development facilities located in 8 countries 

Clinical research conducted in more than 55 countries 

Manufacturing plants located in 8 countries, including the U.S.A., Ireland, Italy, France and Spain.

Approximately 33,000 employees worldwide 

14,707 employees in the US (Dec 2019)

18,917 employees outside US (Dec 2019)

1,700 employees in Ireland (Dec 2019)

Percentage of Lilly Ireland leadership positions occupied by women: 65% (Dec 2019)

Raised $13.4 million for United Way through the generosity of our employees and retirees and a match from the Lilly Foundation. (2019)

19,000 young people received Lilly insulin donated through Life for a Child last year

35,000 people screened for breast and cervical cancer in Kenya through AMPATH partnership

1.2 million employee volunteer hours through Lilly Global Day of Service

Average cost to discover and develop a new drug: $2.6 billion

Average length of time from discovery to patient: 10 years